SH3GL1 antisense RNA 1 (SH3GL1-AS1)

SH3GL1 antisense RNA 1 (SH3GL1-AS1) is a long non-coding natural antisense RNA (ncNAT) transcribed from the opposite strand of the SH3GL1 (endophilin A2) locus. Like other antisense RNAs, SH3GL1-AS1 is thought to modulate the expression and promoter usage of its sense gene partner, SH3GL1, through epigenetic or transcriptional mechanisms. The expression patterns and functional data suggest a role in context-dependent regulation of SH3GL1 gene isoforms, which may indirectly affect cellular processes where SH3GL1 is involved, such as endocytosis, signal transduction, and potentially oncogenesis, though specific disease associations or direct druggability as a therapeutic target have not been established. SH3GL1-AS1 is not a protein-coding gene and is not a classical therapeutic target like a receptor, enzyme, or transporter. There is no evidence of direct drug interaction, biomarker status, or safety concerns described for SH3GL1-AS1. Disease roles and biological functions are inferred based on its regulatory impact on SH3GL1 rather than independent function or pathological mutations. Some confusion is possible between SH3GL1 (the protein) and SH3GL1-AS1 (the antisense RNA). The main target function and therapeutic relevance resides with SH3GL1 (endophilin A2) itself, not the antisense transcript.

Other names

SH3GL1-AS1non-coding natural antisense transcript of SH3GL1ncNAT SH3GL1-AS1